Searchable abstracts of presentations at key conferences in endocrinology

ea0090p623 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Hirata disease: a rare cause of hypoglycemia

Rusu Eva , Stanoiu- Pinzariu Oana , Emanuela Georgescu Carmen

Introduction: Hirata disease (or Insulin autoimmune syndrome) is characterized by the presence of high concentrations of insulin autoantibodies leading to hyperinsulinemic hypoglycemia in individuals with no history of prior exposure to exogenous insulin. Etiopathogenesis is not completely elucidated, it’s considered to result from the interaction of genetic predisposition and environmental triggers such as: medications (methimazole, carbimazole, alpha-lipoic acid, captop...

ea0090p492 | Thyroid | ECE2023

Resistance to Thyroid Hormone Beta in a 12-Year-Old Patient: Clinical, Laboratory, and Molecular Characteristics

Lozovanu Vera , Alina Silaghi Cristina , Emanuela Georgescu Carmen

Background: Resistance to thyroid hormone beta (RTHβ) is an inherited syndrome of reduced tissue responsiveness to thyroid hormones (THs). It is driven in 85% of cases by mutations in the thyroid hormone receptor beta (THRb). The estimated incidence is 1:40.000 to 1:19.000 live births. We report the clinical, laboratory, and genetic analysis of a patient with this disorder.Case report: A 12-year-old boy with a history of Attention-Deficit/H...

ea0063p420 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Premature ovarian failure in a patient with schmidt syndrome

Valea Ana , Moldovan Cristina , Hritiuc Andreea , Agachi Irina , Carsote Mara , Emanuela Georgescu Carmen

Introduction: Premature ovarian failure (POF) may be a part of autoimmune polyglandular syndromes that involves multiple endocrine and systemic conditions due to autoimmunity.Material and methods: We aim to present the case of a young women diagnosed with POF and Schmidt syndrome. The patient was followed in different tertiary centers of endocrinology. The informed consent was obtained.Case report: A 31-year old patient with no pri...

ea0041ep51 | Adrenal cortex (to include Cushing's) | ECE2016

Pediatric Cushing’s disease and paraduodenal tumor

Valea Ana , Breaban Maria , Carsote Mara , Morar Andra , Dumitru Pop Dan , Emanuela Georgescu Carmen , Ghervan Cristina

Introduction: Cushing’s disease (CD) in youth represents a challenge especially related to the therapy and long-term management.Materials and methods: We report the medical history of a child with CD who was followed-up for 7 years. Suggestive endocrine panel and imagery is exposed.Case presentation: A 19-year female was diagnosed at age of 12 with CD. Clinical assessment revealed: weight gain, headache, hyperpigmentation pred...

ea0041ep936 | Pituitary - Clinical | ECE2016

Mesocorticotropinoma- associated Nelson’s syndrome: 28 years of follow-up

Marcusan Alexandra , Morar Andra , Carsote Mara , Dumitru Pop Dan , Ghervan Cristina , Emanuela Georgescu Carmen , Valea Ana

Introduction: Nelson’s syndrome (NS) is an exceptionally rare condition diagnosed sometimes after bilateral suprarenalectomy for Cushing’s disease (CS) involving rapid enlargement of a pre-existing ACTH-secreting pituitary tumor. The clinical picture varies from hyperpigmentation, headache and visual disturbance to diabetes insipidus and hypopituitarism if the hypothalamic-pituitary portal system is disrupted or normal pituitary tissue is destroyed by the adenoma. Th...

ea0070aep638 | Pituitary and Neuroendocrinology | ECE2020

46XY DSD as initial clinical presentation in a patient with syndromic combined pituitary hormones deficiency

Lozovanu Vera , Emanuela Georgescu Carmen , Oana Irimia Ramona , Alina Silaghi Cristina

Background: Combined pituitary hormone deficiency (CPHD) is characterized by multiple pituitary hormone deficiencies, due to mutations of pituitary transcription factors involved in pituitary ontogenesis. The genetic basis for CPHD is complex, involving a variety of syndromic and non-syndromic presentations with variable degrees of phenotype-genotype correlations. In male infants with CPHD, gonadotropin deficiency is suggested by the presence of a microphallus and undescended ...

ea0070ep549 | Hot topics (including COVID-19) | ECE2020

Precocious pseudopuberty with central progression due to McCune-Albright Syndrome: case report

Lungu Ionela , Emanuela Georgescu Carmen , Al-Khzouz Camelia , Asavoaie Carmen , Alina Silaghi Cristina

McCune-Albright Syndrome (MAS) is a rare congenital sporadic disorder due to an embryonic post-zygotic somatic mutation in the GNAS1 gene, defined by the triad of peripheral precocious puberty (PPP), unilateral café-au-lait spots and fibrous dysplasia (FD) of bone. PPP or precocious pseudopuberty is the most common endocrinopathy seen in MAS. Other hyperfunctioning endocrinopathies include hyperthyroidism, acromegaly, FGF23-mediated hypophosphatemia and neonatal hypercort...

ea0090p434 | Pituitary and Neuroendocrinology | ECE2023

Awaken a sleeping giant: Incidentally discovered pituitary gigantism

Rusu Eva , Peica Andreea , Gliga Tudor , Milea Gheorghe Ana , Adrian Radu Mircea , Stanoiu- Pinzariu Oana , Emanuela Georgescu Carmen

Introduction: Pituitary gigantism is a rare disorder characterized by growth hormone (GH) excess that occurs before epiphyseal growth plates fusion leading to rapid and excessive linear growth in childhood and very tall adult stature. It can be sporadic or coexist with genetic disorders such as FIPA, X-LAG, McCune-Albright, Carney complex, MEN 1 or 4, and Neurofibromatosis type 1.Case report: We present a case of a 12 years old boy with no medical histor...

ea0070aep661 | Pituitary and Neuroendocrinology | ECE2020

Metyrapone treatment in endogenous Cushing’s syndrome. Results from a prospective multicenter, open-label, phase III/IV study: Prompt

Nieman Lynnette , Boscaro Marco , Carla Scaroni , Deutschbein Timo , Mezosi Emese , Driessens Natacha , Emanuela Georgescu Carmen , Hubalewska-Dydejczyk Alicja , Berker Dilek , Jarzab Barbara , Maiter Dominique , Reincke Martin , Loli Paola , Zampetti Benedetta , Atmaca Aysegul , Badiu Corin , Beckers Albert , Bolanowski Marek , Cavagnini Francesco , Unger Nicole , Giordano Roberta , Hanzu Felicia , Terzolo Massimo , Bostnavaron Martine , Marsault Pauline , Toth Miklos

Metyrapone treatment in endogenous Cushing’s syndrome. Results from a prospective multicenter, open-label, phase III/IV study: PROMPTBackground: Metyrapone is a steroidogenesis inhibitor approved in Europe for the treatment of endogenous Cushing’s syndrome (CS) based on observational retrospective studies published over more than 50 years. We present data from the first prospective study designed to confirm metyrapone efficacy and good tolera...